Hospitalizations in patients with idiopathic pulmonary fibrosis
Autor: | Anna J. Podolanczuk, Joao A. Andrade, Nishant Gupta, Ather Siddiqi, Megan L. Neely, David J. Lederer, Nina Patel, Jesse Roman, Murali Ramaswamy, Rajat Walia, Yolanda Mageto, Shirin Shafazand, Amy Hajari Case, Joseph A. Lasky, Doug Lee, Kalpalatha K. Guntupalli, Mark P. Steele, Wael Asi, Hyun J Kim, Tracy Luckhardt, Timothy Liesching, Paul Sachs, Mary E. Strek, Sally Suliman, Kevin F. Gibson, Laurie D. Snyder, David Hotchkin, Randolph J. Lipchik, Kevin R. Flaherty, Eric S. White, Justin M. Oldham, Timothy P.M. Whelan, Mary K. Porteous, Imre Noth, Craig S Conoscenti, Prema Menon, Daniel F. Dilling, Jeremy Tabak, John Fitzgerald, Scott Beegle, Marilyn K. Glassberg, Lisa Lancaster, Francis Cordova, Rishi Raj, Tessy Paul, Paul Mohabir, Mridu Gulati, Ayodeji Adegunsoye, Andrew Namen, Tristan J. Huie, Robert J. Kaner, Lake Morrison, Leann Silhan, Rany Condos, David Zhang, Zeenat Safdar, John A. Belperio, Maryl Kreider, Albert Baker, Daniel A. Culver, Tonya D. Russell, Howard J. Huang, Shaun Bender, Barry Sigal, Jason Lobo |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Male
medicine.medical_specialty Time Factors medicine.medical_treatment Interstitial lung disease Patient Readmission Risk Assessment Pulmonary fibrosis Diseases of the respiratory system Idiopathic pulmonary fibrosis FEV1/FVC ratio Mechanical ventilation Risk Factors Internal medicine medicine Risk of mortality Humans Hospital Mortality Registries Mortality Aged Retrospective Studies RC705-779 Proportional hazards model business.industry Research Respiratory function tests medicine.disease Prognosis Pulmonary hypertension Respiration Artificial Idiopathic Pulmonary Fibrosis Patient Discharge United States Hospitalization Female business |
Zdroj: | Respiratory Research Respiratory Research, Vol 22, Iss 1, Pp 1-9 (2021) |
ISSN: | 1465-993X 1465-9921 |
Popis: | Background Hospitalizations are common among patients with idiopathic pulmonary fibrosis (IPF). We investigated the impact of hospitalizations on outcomes in patients with IPF. Methods The IPF-PRO Registry is an observational US registry that enrolled patients with IPF that was diagnosed or confirmed at the enrolling center in the previous 6 months. Associations between patient characteristics and hospitalization, and between hospitalization and mortality, were analyzed using Cox regression models. Results A total of 1002 patients with IPF were enrolled into the IPF-PRO Registry. Over a median follow-up time of 23.7 months (maximum: 67.0 months), 568 patients (56.7%) had at least one hospitalization. Of these patients, 319 (56.2%) had at least one respiratory-related hospitalization and 120 (21.1%) had at least one hospitalization with ventilatory support. Younger age (HR 0.68 [95% CI 0.55, 0.84] per 5-year increase for patients Conclusions Data from the IPF-PRO Registry demonstrate that hospitalizations are common among patients with IPF. The risk of mortality during hospitalization or within 90 days of discharge was high, particularly among patients who were hospitalized for a respiratory cause or received ventilatory support. Trial registration ClinicalTrials.gov, NCT01915511. Registered 5 August 2013, https://clinicaltrials.gov/ct2/show/NCT01915511 |
Databáze: | OpenAIRE |
Externí odkaz: |